These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21544403)

  • 21. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of three strains of feline fibrosarcoma virus grown in cat and marmoset monkey cells.
    McDonald R; Thakkar B; Wolfe LG; Deinhardt F
    Int J Cancer; 1976 Mar; 17(3):396-406. PubMed ID: 176119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nature of immunity to Snyder-Theilen fibrosarcoma virus induced tumors in cats.
    Johnson L; Pedersen NC; Theilen GH
    Vet Immunol Immunopathol; 1985 Jul; 9(3):283-300. PubMed ID: 2994282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in mechanisms of transformation by independent feline sarcoma virus isolates.
    Reynolds FH; Van de Ven WJ; Blomberg J; Stephenson JR
    J Virol; 1981 Jun; 38(3):1084-9. PubMed ID: 6165838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the primary translational product and integrated DNA of a new feline sarcoma virus, GR-FeSV.
    Naharro G; Dunn CY; Robbins KC
    Virology; 1983 Mar; 125(2):502-7. PubMed ID: 6601328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to feline sarcoma virus gag and fes gene translational products.
    Veronese F; Kelloff GJ; Reynolds FH; Hill RW; Stephenson JR
    J Cell Biochem; 1983; 21(1):9-18. PubMed ID: 6308016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of subgroup-specific feline oncornavirus-neutralizing antibody.
    Schaller JP; Olsen RG
    Infect Immun; 1975 Dec; 12(6):1405-10. PubMed ID: 173656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feline sarcoma virus in vitro infection of human cells. Influence of chemical carcinogens on focus formation.
    Blakeslee JR; Milo GE
    Chem Biol Interact; 1978 Oct; 23(1):1-11. PubMed ID: 81113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TP1 isolate of feline sarcoma virus encodes a fgr-related oncogene lacking gamma actin sequences.
    Kappes B; Ziemiecki A; Müller RG; Theilen GH; Bauer H; Barnekow A
    Oncogene; 1989 Mar; 4(3):363-72. PubMed ID: 2539576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus.
    Azocar J; Essex M
    J Natl Cancer Inst; 1979 Nov; 63(5):1179-84. PubMed ID: 228103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of retroviral tumors in hosts immune to viral oncogene product.
    Maruyama K; Miyauchi M; Mochizuki S; Fukushima T; Koshikawa N; Kawamura K; Awaya A; Kobayashi H
    Leukemia; 1994 Apr; 8 Suppl 1():S190-3. PubMed ID: 8152290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay.
    Sherr CJ; Todaro GJ; Sliski A; Essex M
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4489-93. PubMed ID: 212755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.
    Sherr CJ; Sen A; Todaro GJ; Sliski A; Essex M
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1505-9. PubMed ID: 206902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of bacille Calmette-Guerin immunotherapy on feline sarcoma virus-induced neoplasms in the cat.
    Bachman D; Cockerell GL; de Noronha F; Rapp HJ
    Am J Vet Res; 1982 Mar; 43(3):475-80. PubMed ID: 6280529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine protein kinase activity of the HZ4-feline sarcoma virus P80gag-kit-transforming protein.
    Majumder S; Ray P; Besmer P
    Oncogene Res; 1990; 5(4):329-35. PubMed ID: 1697669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A beta-type transforming growth factor, present in conditioned cell culture medium independent of cell transformation, may derive from serum.
    Stromberg K; Twardzik DR
    J Cell Biochem; 1985; 27(4):443-8. PubMed ID: 2987278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of regional and distant lymph nodes in rejection of feline sarcoma virus-induced tumors in sheep.
    Thellen GH; Pedersen NC; Higgins J
    J Natl Cancer Inst; 1979 Aug; 63(2):389-400. PubMed ID: 222930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies of predetermined specificity detect two retroviral oncogene products and inhibit their kinase activities.
    Sen S; Houghten RA; Sherr CJ; Sen A
    Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1246-50. PubMed ID: 6572383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
    Hoover EA; Olsen RG; Mathes LE; Schaller JP
    Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombomodulin induction by all-trans retinoic acid is independent of HL-60 cells differentiation to neutrophilic cells.
    Kizaki K; Ishii H; Horie S; Kazama M
    Thromb Haemost; 1994 Oct; 72(4):573-7. PubMed ID: 7878635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.